Sow Good Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Sow Good Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $16.07M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $428.1K | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $88.4K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $466.6K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $0 | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $1.00M | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $1.05M | Apr 12, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $12.98M | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | $3.28M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $119.8K | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $7.1K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Mar 29, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($40.64M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($3.70M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($3.06M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($12.13M) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($6.87M) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($5.32M) | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $4.13M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($344.0K) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | ($392.5K) | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $29.95M | Apr 12, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.61M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($11.09M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($1.22M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($10.89M) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($7.11M) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($3.01M) | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | ($2.60M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($1.88M) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | ($1.45M) | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | ($1.48M) | Apr 12, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.57M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $11.06M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $4.39M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $10.73M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $6.91M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $3.01M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $3.06M | Mar 31, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($4.31M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($9.43M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($4.85M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($5.15M) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($5.55M) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($1.74M) | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | ($9.71M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($187.9K) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | ($792.3K) | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $2.95M | Apr 12, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $6.0K | May 15, 2020 |
| FY2019 | Dec 31, 2018 | $0 | May 15, 2020 |
| FY2015 | Dec 31, 2015 | $0 | Mar 30, 2016 |
| FY2015 | Dec 31, 2014 | $23.5K | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $38.5K | Mar 30, 2015 |
| FY2013 | Dec 31, 2012 | $7.4K | Mar 27, 2014 |
| FY2012 | Dec 31, 2011 | $78.5K | Mar 28, 2013 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.78M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $54.70M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $21.49M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $8.90M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $14.10M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $12.34M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $7.15M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $142.87M | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $140.56M | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $235.2K | Apr 12, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.34M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $22.71M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $14.21M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $6.09M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $3.28M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $2.29M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $1.45M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $659.4K | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $186.7K | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $36.6K | Apr 12, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.56M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $31.99M | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | $7.28M | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | $2.81M | Mar 27, 2025 |
| FY2023 | Dec 31, 2021 | $10.82M | Mar 22, 2024 |
| FY2022 | Dec 31, 2020 | $10.06M | Apr 14, 2023 |
| FY2021 | Dec 31, 2019 | $5.70M | Mar 29, 2022 |
| FY2020 | Dec 31, 2018 | $1.47M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $1.50M | May 15, 2020 |
| FY2018 | Dec 31, 2016 | $198.6K | Mar 22, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | Apr 14, 2023 |
| FY2022 | Dec 31, 2021 | $4.89M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $6.41M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $0 | Mar 31, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($103.08M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($62.44M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($58.74M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($55.68M) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($43.55M) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($36.68M) | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | ($31.36M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($35.49M) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | ($35.14M) | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | ($34.75M) | Apr 12, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.47M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $3.72M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $2.41M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $276.5K | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $3.35M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $1.91M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $108.8K | Mar 31, 2021 |
| FY2020 | Dec 31, 2018 | $1.50M | Mar 31, 2021 |
| FY2020 | Dec 31, 2017 | $1.48M | Mar 31, 2021 |
| FY2018 | Dec 31, 2016 | $66.3K | Mar 22, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2015 | $0 | Apr 6, 2017 |
| FY2015 | Dec 31, 2014 | $51.83M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $2.65M | Mar 30, 2015 |
| FY2013 | Dec 31, 2012 | $0 | Mar 27, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (3) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | (2) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | (1) | Apr 14, 2023 |
| FY2020 | Dec 31, 2020 | (2) | Mar 31, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | May 15, 2020 |
| FY2016 | Dec 31, 2016 | 0 | Apr 6, 2017 |
| FY2016 | Dec 31, 2015 | (1) | Apr 6, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (3) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 27, 2025 |
| FY2022 | Dec 31, 2022 | (2) | Apr 14, 2023 |
| FY2022 | Dec 31, 2021 | (1) | Apr 14, 2023 |
| FY2020 | Dec 31, 2020 | (2) | Mar 31, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | May 15, 2020 |
| FY2016 | Dec 31, 2016 | 0 | Apr 6, 2017 |
| FY2016 | Dec 31, 2015 | (1) | Apr 6, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.22M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 11.30M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 6.03M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 4.85M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | 4.81M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | 2.74M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | 1.60M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 1.60M | May 15, 2020 |
| FY2018 | Dec 31, 2017 | 479.80M | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | 47.98M | Apr 12, 2018 |